Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 44.00
Bid: 43.80
Ask: 44.50
Change: -0.85 (-1.89%)
Spread: 0.70 (1.598%)
Open: 44.00
High: 44.00
Low: 44.00
Prev. Close: 45.00
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of remaining minority interest

17 Feb 2023 07:00

RNS Number : 2196Q
Benchmark Holdings PLC
17 February 2023
 

RNS Reach

17 February 2023

Benchmark Holdings plc

("Benchmark", the Group, or the "Company")

Acquisition of remaining minority interest in Benchmark Genetics Iceland

Benchmark Holdings, the aquaculture biotechnology company, announces that it has acquired the remaining 10.52% minority interest in its subsidiary Benchmark Genetics Iceland. Enhanced by the recent construction of a new incubation centre, Benchmark Genetics Iceland is core to the Company's ability to supply highly specialist, biosecure salmon eggs to salmon producers to c.35 countries around the world, year-round. Benchmark Genetics Iceland represents 50% of the Group's salmon egg capacity.

Background

In December 2014 Benchmark acquired a 89.48% interest in Stofnfiskur, subsequently rebranding it Benchmark Genetics Iceland and merging it with its salmon genetics business in Norway. Since the acquisition, the business has grown substantially, benefitting from Benchmark's leading market position, investment and knowledge transfer within the Group. 

Trond Williksen commented:

"Benchmark's genetics operations in Iceland have a 200m egg capacity and are core to our ability to supply highly biosecure salmon eggs year round to customers around the world. The acquisition of the remaining minority interest is a natural step in delivering shareholder value through full ownership of the success of our genetics business."

Rabobank acted as financial adviser to Benchmark in the transaction.

Enquiries

For further information, please contact:

Benchmark Holdings plc

Tel: 020 3696 0630

Trond Williksen, CEO

Septima Maguire, CFO

Ivonne Cantu, Investor Relations

Numis (Broker and NOMAD)

Tel: 020 7260 1000

James Black, Freddie Barnfield, Duncan Monteith

 

MHP

Tel: 020 3128 8004

Katie Hunt, Reg Hoare, Veronica Farah

benchmark@mhpgroup.com

 

About Benchmark 

Benchmark is a market leading aquaculture biotechnology company. Benchmark's mission is to drive sustainability in aquaculture by delivering products and solutions in genetics, advanced nutrition and health which improve yield, growth and animal health and welfare.

Through a global footprint in 26 countries and a broad portfolio of products and solutions, Benchmark serves major aquaculture species - salmon, shrimp, sea bass and bream and tilapia - in main aquaculture regions around the world. Find out more at www.benchmarkplc.com

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRATFMBTMTBBTRJ
Date   Source Headline
30th Apr 202410:55 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
26th Apr 20244:18 pmRNSForm 8.3 - BENCHMARK HOLDINGS PLC
26th Apr 20241:54 pmRNSNotice of Q2 and Interim Results
25th Apr 20247:00 amRNSForm 8.3 - BENCHMARK HOLDINGS PLC
23rd Apr 202410:44 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
23rd Apr 20247:00 amRNSRule 2.9 Announcement
22nd Apr 202410:42 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
19th Apr 20249:23 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
18th Apr 202410:37 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
17th Apr 20244:13 pmRNSFORM 8.3 - BENCHMARK HOLDINGS PLC
17th Apr 202410:27 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
16th Apr 20249:54 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
11th Apr 202410:51 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
8th Apr 202411:26 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
5th Apr 202410:38 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
5th Apr 20249:23 amRNSForm 8.3 - Benchmark Holdings plc
28th Mar 202412:00 pmRNSTotal Voting Rights
22nd Mar 202411:51 amRNSForm 8.3 - Benchmark Holdings plc
22nd Mar 202410:52 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
22nd Mar 202410:33 amRNSBENCHMARK Holdings PLC
21st Mar 20249:58 amRNSForm 8.3 - Benchmark Holdings plc
21st Mar 20247:00 amRNSBlock Listing Six Monthly Return
20th Mar 202411:28 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
19th Mar 202410:01 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
15th Mar 202411:13 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
7th Mar 202411:26 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
7th Mar 20247:00 amRNSRule 2.9 Announcement
6th Mar 202410:36 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
5th Mar 202411:10 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
4th Mar 20243:13 pmGNWForm 8.3 - [BENCHMARK HOLDINGS PLC - 01 03 2024] - (CGAML)
4th Mar 202411:22 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
29th Feb 202411:19 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
29th Feb 20247:00 amRNSTotal Voting Rights
27th Feb 202411:24 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
26th Feb 202411:06 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
23rd Feb 202411:23 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
22nd Feb 20243:15 pmRNSForm 8.3 - BENCHMARK HOLDINGS PLC
21st Feb 202411:24 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
20th Feb 202411:40 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
19th Feb 202410:59 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
16th Feb 202410:26 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc
15th Feb 20247:00 amRNSQ1 Results
14th Feb 202411:37 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
8th Feb 20244:00 pmRNSResult of AGM
6th Feb 20244:08 pmRNSForm 8.3 - Benchmark Holdings PLC
6th Feb 20247:36 amRNSForm 8.3 - Benchmark Holdings PLC
5th Feb 20245:30 pmRNSRule 2.9 Announcement
5th Feb 20242:50 pmRNSForm 8.3 - Benchmark Holdings PLC
5th Feb 202410:20 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings Plc
1st Feb 202410:26 amRNSForm 8.5 (EPT/RI) - Benchmark Holdings plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.